BioMarin Pharmaceutical Inc. (BM8.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 04:58PM CEST
| Previous close | 80.74 |
| Open | 80.74 |
| Bid | 75.92 x 2300 |
| Ask | 75.98 x 2200 |
| Day's range | 76.62 - 76.94 |
| 52-week range | 70.78 - 90.52 |
| Volume | |
| Avg. volume | 5 |
| Market cap | 14.541B |
| Beta (5Y monthly) | 0.32 |
| PE ratio (TTM) | 77.39 |
| EPS (TTM) | 0.99 |
| Earnings date | 24 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 110.83 |
GuruFocus.comBeyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)
Insightful Analysis of Biomarin Pharmaceutical Inc's Strengths, Weaknesses, Opportunities, and Threats
Insider MonkeyBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript April 24, 2024 BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.71, expectations were $0.6. BioMarin Pharmaceutical Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name […]
Simply Wall St.BioMarin Pharmaceutical First Quarter 2024 Earnings: EPS Beats Expectations
BioMarin Pharmaceutical ( NASDAQ:BMRN ) First Quarter 2024 Results Key Financial Results Revenue: US$648.8m (up 8.8...
© 2024 Yahoo. All rights reserved.